Press Releases

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended September 30, 2019."We are pleased to see continued growth during the quarter in the total number of U.S. patients treated with our prostacyclin product franc

SAN DIEGO, Oct. 30, 2019 /PRNewswire/ -- Invivoscribe, Inc. announced today that the European Commission (EC) has approved the Astellas drug XOSPATA™ (gilteritinib) as a monotherapy for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with FLT3 mutations (FLT3mut+) detected using Invivoscrib

TAMPA, Fla., Oct. 30, 2019 /PRNewswire/ -- WellCare Health Plans, Inc. (NYSE: WCG) ("WellCare") today reported results for the quarter ended September 30, 2019. As determined under generally accepted accounting principles (GAAP), net income for the third quarter of 2019 was $241.0 million, or

SAN FRANCISCO, Oct. 30, 2019 /PRNewswire/ -- Today Doximity, the largest professional medical network, released a new study that illuminates an emerging women's cancer care crisis. Cancer is

NORTH CHICAGO, Ill., Oct. 30, 2019 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of October 28, 2019 its issued share capital, excluding treasury shares, is comprised of 1,478,821,109 shares of common stock with a par value of $0.01

ROSEMONT, Ill., Oct. 30, 2019 /PRNewswire/ -- A large new study has found that an artery disease that mostly affects legs and feet is associated with increased use of opioids, the Society for Vascular Surgery reports. Researchers discovered that some patients who had a procedure to improve pain from poor circulation actually increased their use of opioids after treatment

ROSEMONT, Ill., Oct. 30, 2019 /PRNewswire/ -- Victor L. Nannini, DDS, FACS, was introduced as the 102nd president of the American Association of Oral and Maxillofacial Surgeons (AAOMS) during its Annual Meeting in September in Boston, Mass.Alongside AAOMS's other officers and its Board of Trustees, Nannini assumes leadership f

STOCKHOLM, Oct. 30, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that a poster entitled "MIV-818 stimulates an anti-tumor immune response in vitro and enhances the effects of pembrolizumab" was presented at the AACR-NCI-EORTC conference in Boston. The data shows that MIV-818 exerts favorable immunom

UPPSALA, Sweden, Oct. 30, 2019 /PRNewswire/ -- Beactica Therapeutics, the Swedish drug discovery company, today announced its participation in a Marie Skłodowska-Curie Innovative Training Network (ITN) called UbiMotif. The ITN is funded with EUR 4.1 million under the European Commission's Horizon 2020 programme and aims to deliver 15 sk

WATERTOWN, Mass., Oct. 30, 2019 /PRNewswire/ -- Arranta Bio ("Arranta") announced today the completion of an $82 million funding round and a strategic partnership with Thermo Fisher Scientific.